NanoPhoria

Description

NanoPhoria develops inhalable Nano-in-Micro delivery formulations to enable tissue-directed delivery of therapeutic peptides and RNAs for cardiovascular diseases, including an inhalable lead product NP-MP1 for HFrEF patients.

Related

• Sangamo Therapeutics ($SGMO)Sangamo Therapeutics develops genomic medicines using zinc finger, delivery, and integrase platforms for patients with severe diseases…
• AplagonAplagon develops first-in-class therapeutics for thromboinflammatory diseases, focusing on clinical-stage drug APAC to treat thrombotic and…
• NTrans TechnologiesNTrans Technologies develops a modular non-viral delivery platform for cell and gene therapies, enabling delivery of gene editors and CAR…
• RS Research Inc.Develops polymer-drug conjugate delivery platforms for targeted chemotherapy and theranostics, used to improve therapeutic index for…
• Verve TherapeuticsSingle-course gene-editing therapies for cardiovascular disease. Cambridge MA; CRISPR-based PCSK9 + ANGPTL3 programs.
• Confo TherapeuticsConfo Therapeutics develops GPCR-directed small molecules and antibody-based therapeutics for metabolic and endocrine diseases, advancing…
• Beam Therapeutics ($BEAM)Beam Therapeutics develops precision genetic medicines using base editing and delivery technologies to create investigational therapies for…
• Dyno TherapeuticsDyno Therapeutics develops AI-driven genetic delivery technologies to design and optimize gene therapies and delivery vectors for use by…
• Cleara BiotechCleara Biotech develops peptide-based therapeutics and biomarkers to selectively eliminate p53-impaired cancer cells, producing D-amino…
• NIMBLE DiagnosticsNIMBLE Diagnostics develops a microwave-based, non-invasive point-of-care system to monitor implanted cardiovascular stents and detect…
• Liquidia ($LQDA)Liquidia develops inhaled therapies for rare cardiopulmonary diseases, including pulmonary arterial hypertension, using proprietary…
• ARTHEX BIOTECH S.L.Develops RNA-based therapeutics, specifically anti-miR oligonucleotides for myotonic dystrophy and other diseases, used by researchers and…